Safa'a Al-Rais

Direttore operativo presso Resilience Biotechnologies, Inc.

Health Technology

Profilo

Safa'a Al-Rais is currently the Chief Operating Officer at Resilience Biotechnologies, Inc. Prior to this, he worked at Therapure Biopharma, Inc. from 2009 to 2020 as the Vice President-Operations.

Posizioni attive di Safa'a Al-Rais

Società	Posizione	Inizio
Resilience Biotechnologies, Inc. Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi.	Direttore operativo	-

Tutte le posizioni attive di Safa'a Al-Rais

Precedenti posizioni note di Safa'a Al-Rais

Società	Posizione	Fine
Therapure Biopharma, Inc. Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada.	Direttore operativo	01/10/2020

Vedi nel dettaglio l'esperienza di Safa'a Al-Rais

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Safa'a Al-Rais

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Therapure Biopharma, Inc. Therapure Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Therapure Biopharma, Inc. engages in the business of contract development and manufacturing. It operates through the following divisions: Therapure Biomanufacturing, Therapure Innovations, and Evolve Biologics. The Therapure Biomanufacturing division focuses on contract development and manufacturing of complex biologics. The Therapure Innovations division includes in-house proprietary-drug development. The Evolve Biologics division develops a portfolio of plasma-derived pharmaceutical products. The company was founded on June 22, 2007 and is headquartered in Mississauga, Canada.	Health Technology
Resilience Biotechnologies, Inc. Resilience Biotechnologies, Inc. BiotechnologyHealth Technology Part of National Resilience, Inc., Resilience Biotechnologies, Inc. operates as a Canadian biotechnology company. The CEO of the company is Rahul Singhvi.	Health Technology